{"name":"Tuberculosis Research Centre, India","slug":"tuberculosis-research-centre-india","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"immunology","drugs":[{"name":"Didanosine, Lamivudine, Nevirapine","genericName":"Didanosine, Lamivudine, Nevirapine","slug":"didanosine-lamivudine-nevirapine","indication":"HIV-1 infection","status":"phase_3"},{"name":"Isoniazid with Ethambutol","genericName":"Isoniazid with Ethambutol","slug":"isoniazid-with-ethambutol","indication":"Tuberculosis (pulmonary and extrapulmonary)","status":"phase_3"},{"name":"Moxifloxacin, Isoniazid, Rifampicin Pyrazinamide, Ethambutol","genericName":"Moxifloxacin, Isoniazid, Rifampicin Pyrazinamide, Ethambutol","slug":"moxifloxacin-isoniazid-rifampicin-pyrazinamide-ethambutol","indication":"Tuberculosis (drug-susceptible and potentially drug-resistant forms)","status":"phase_3"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"BCG vaccine (Freeze-dried)","genericName":"BCG vaccine (Freeze-dried)","slug":"bcg-vaccine-freeze-dried","indication":"Tuberculosis prevention (primary indication)","status":"phase_3"}]}],"pipeline":[{"name":"BCG vaccine (Freeze-dried)","genericName":"BCG vaccine (Freeze-dried)","slug":"bcg-vaccine-freeze-dried","phase":"phase_3","mechanism":"BCG vaccine stimulates the immune system to recognize and attack Mycobacterium tuberculosis by activating T-cell and macrophage-mediated immunity.","indications":["Tuberculosis prevention (primary indication)","Bladder cancer (intravesical BCG therapy)"],"catalyst":""},{"name":"Didanosine, Lamivudine, Nevirapine","genericName":"Didanosine, Lamivudine, Nevirapine","slug":"didanosine-lamivudine-nevirapine","phase":"phase_3","mechanism":"This is a fixed-dose combination of three nucleoside/non-nucleoside reverse transcriptase inhibitors that block HIV replication by inhibiting the enzyme responsible for converting viral RNA into DNA.","indications":["HIV-1 infection"],"catalyst":""},{"name":"Isoniazid with Ethambutol","genericName":"Isoniazid with Ethambutol","slug":"isoniazid-with-ethambutol","phase":"phase_3","mechanism":"Isoniazid and ethambutol are bactericidal and bacteriostatic agents that inhibit mycobacterial cell wall and metabolic synthesis, respectively, to treat tuberculosis infection.","indications":["Tuberculosis (pulmonary and extrapulmonary)"],"catalyst":""},{"name":"Moxifloxacin, Isoniazid, Rifampicin Pyrazinamide, Ethambutol","genericName":"Moxifloxacin, Isoniazid, Rifampicin Pyrazinamide, Ethambutol","slug":"moxifloxacin-isoniazid-rifampicin-pyrazinamide-ethambutol","phase":"phase_3","mechanism":"This is a fixed-dose combination of five anti-tuberculosis drugs that work synergistically to inhibit bacterial cell wall synthesis and protein production, killing Mycobacterium tuberculosis through multiple mechanisms.","indications":["Tuberculosis (drug-susceptible and potentially drug-resistant forms)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxPYmZJOWJPdzQtWElvbFY3TDlpTmk2Vm5TNGJXZlVMSjUwZm9kTVpWdFIta0FLN2RsVGxlNFVoNnBYRFg4dE4tZXJtVDNTUjU1STFXdlM3UnViYnhuTE1mYVFLNU01SDlqMktfZHNkQWdaM2tKMk9Xa19lVDUtejg4WVRTN19BTFN4NV9WZXJCai11Y1FEZmY3OVJmYTF6S2pNODl2UE1iVGFhQy1T0gGzAUFVX3lxTE1fQmd2ODRPOGp5X2VuT3puSHM3eURTc2hyREhlYXUzTlVXTW51Z1hXLVB0bGdxNEVEbVpmUFlNbVVNQzE5a3FENjlXeURYRW5feUlXQ25fVXl0RDFCQkszaTNHRmxiLW1HR1FVb2R5bEpOaHIwWjZzUVhSTDhJR0ozSDdIN001VHJETzJKMEczUUZIVHk4VzlFeGY4Uk1vdlJmeGRzRmJXczJJVzBNWGozR3Q0?oc=5","date":"2026-04-08","type":"pipeline","source":"Indian Pharma Post","summary":"Thailand and GHIT Fund join forces to tackle infectious diseases - Indian Pharma Post","headline":"Thailand and GHIT Fund join forces to tackle infectious diseases","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-25","type":"trial","source":"Express Pharma","summary":"Ministry of Ayush and DBT announce collaborative clinical study on ayurveda as adjunct therapy for Anti-TB treatment - Express Pharma","headline":"Ministry of Ayush and DBT announce collaborative clinical study on ayurveda as adjunct therapy for Anti-TB treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPU3NDNGR6S2VfYnNwMnpfYUJqR3dFWUJkUXQzYVZicjZseklHcktPeXJJSThJQm9PRm5LbVRJeDVVV1RwMFQ5ZTl1OXFXVGhIZEExd3FNVUdLNDNpNmpmb3l0cjBQb3hvVEpKdUE1VnVyT2JjUUZSN1BYRUFGRVhaUUlfUDJhNmQzX0FqRWZBdkFfbVppbHZOU2V2LTY?oc=5","date":"2026-03-11","type":"pipeline","source":"Think Global Health","summary":"Indonesia in the BRICS: What It Means for Global Health - Think Global Health","headline":"Indonesia in the BRICS: What It Means for Global Health","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxQS1duWjU4R1lGZXpzZFRvZ2ZKRmdaUmpUTDV2YUlwYW1xSWM2d2t2NTFERmtJdEE4b1pHU1pNLWNoTUVxUmV0UHNhZWlJYV9ndWRnRWRsdTM2a3J0R1NBWUoyaDBieHFIdWFVYk53dUc1Z21lUE5kNmMyazRwbDZqbFYyZzF4UDJMLVFtR04tTUh6eGFHaWlKa3dISkxVOENQQzV4cndjRnVIVGxtOUVCeVhBaXg0MnVOcmh4S0h3?oc=5","date":"2026-02-20","type":"pipeline","source":"BW Healthcare World","summary":"Sharda Hospital Launches India’s First Centre For MDR-TB Drug Monitoring - BW Healthcare World","headline":"Sharda Hospital Launches India’s First Centre For MDR-TB Drug Monitoring","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxOSjVscUZoVlNLQS03QnYzQXFBMFV4YlFuaFhfdmU1TGFwUmQzT2ZaNVpaTHZEWndURDdXZG9GSkNZQUVMZFFBTy1lTm1iSG0za2V3TURmNlhRZ3lXYVVlaTRRVDM4MjR2aE1uTnJpclQtR0lHUmhENWpVUXRFeUZXNmtBczhzTVhwOXFXZ21uUEFrSmVGTHdGcEFGclBNN1Y4c3lXbndYTGJtWkJTOHFoVnlxUzFiNXZ3TThJY196cEtoa3JmaFFjWWR3Yl9EbFlQMUZXT2MxN0Q3c1Q4RTJxakVkMA?oc=5","date":"2026-02-18","type":"pipeline","source":"BioSpectrum India","summary":"Sharda Hospital establishes India’s first Centre for Drug Quantification to strengthen MDR-TB care - BioSpectrum India","headline":"Sharda Hospital establishes India’s first Centre for Drug Quantification to strengthen MDR-TB care","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxNMkp0Tzl2c3hWdlNUQzV0Zmx2eW1OeUtaQXotNGFreGtnMkF0ZVd2T2RRb3FYZ0h3TjByZkZTUDEybzJBc0JkSnJMclBERmhFampqOWItcGhPLWNJRzlBZGI4SHVZMjVDYzVITEhPMnM0N3U2M19mMzlRNG50cGttWkN5TVpLUjktZ0o5WjRVUk1vVGNuZVpSRWNqM1BLeEJQeFpheTlhdjdnM0VIYkRzNl9mZmJOcVRxVEZycWlxQnNtVV8xdThyUy1GNUxzWkM0LUhKNHNrVjZFM0dfU3d4dW9xZE5DQ3JvVTVQMHJqUzBEYkJ2a3VJ?oc=5","date":"2026-02-02","type":"pipeline","source":"lupin.com","summary":"Lupin and TB Alliance Join Forces to Advance Telacebec for the Treatment of Tuberculosis and Other Mycobacterial Diseases - Lupin | Press Release - lupin.com","headline":"Lupin and TB Alliance Join Forces to Advance Telacebec for the Treatment of Tuberculosis and Other Mycobacterial Disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAJBVV95cUxPWEZyd1hOQzFxWFdET2NWN3NmaVRsZ09nVXI2R3ZDdTFfQUwwWGlZVXR1NlhncjMzRTBBYWpiejI1bHZHN1pTeTZoVi1uMkZyRVJZcUUtdXpGT3h3b3R2UmN6R1dBSFdRYnBLcjJmUl9kc2JYSkFfOG85cE5HeDFMNkVEenJDSF9HQXA5QTViSkkzLWUzRy1VVzVsdktoVlREOVRta3Y5VTZ1OThhMmhNQ2ExRVBlZUxTTnpOenVsdUNEUzhaUFZJMkxJel96VHVET3Nzamx0aUlTODdTa1luM2lpejVCOHIyLWNhOVE0amVsOXJILVUtbzU0bVNMUmJ6cFhVOXczal9ZTzlSWG5WQkV2a0JKbW1BbjdJZEoyemY?oc=5","date":"2025-01-22","type":"trial","source":"prnewswire.com","summary":"Tuberculosis Clinical Trial Pipeline Appears Robust With 30+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - prnewswire.com","headline":"Tuberculosis Clinical Trial Pipeline Appears Robust With 30+ Key Pharma Companies Actively Working in the Therapeutics S","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNOXVGbkptUzBpaUExbWJUbXB1SFlpdEFHaXY0MlJHV0taR2ZhSXQzZ29Ga3FsUDl5ZXJoQXNRYXAwX2M5UVFidzFFcExhVDVjMDZaZEpDMXdnT2hHcUhZWWx0MGJ0OGtEc0RxdHdoMVdpejk1eHRrQUMtTzZmMElaQWVuVWNzZ3JpZ1o0?oc=5","date":"2024-03-19","type":"regulatory","source":"The Lancet","summary":"Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021 - The Lancet","headline":"Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systemati","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQUkhuakFHbkVxcDVKUHR6cEpKUzkxeHhCclY5dEFZWUVQWnJKZnFxMzUyWUFETWJDanRDeHhwVUJZSXRfcE8zaXpMbGpHZXdneWJMZDhLNXNVczhKX2ZhSjdhcjJGWkZWUjlMYWJZMktHTzV2SWtUWEtkSFdyV3RFYjZyVGFaQ3RXTE1WUUdkazFMTUpw?oc=5","date":"2024-02-06","type":"regulatory","source":"Frontiers","summary":"Clinical pharmacy services for tuberculosis management: a systematic review - Frontiers","headline":"Clinical pharmacy services for tuberculosis management: a systematic review","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPNG1VcXVPZ2VsVWpmTzVLOGhyaE9MS2UzaE9PYUlXcXlSUnBSV3RfVWZXOGJpR1RTM1ZMdUJ3M1A0bmlmaDl4Z0w2Tm9HVmI3a0xxT3c2cVlCT2dMRzdaa0hKanZIaWt5NXFCVjB3OGFtUzBnNF9KVFRqSmN5Z2dqanhoX1NzcG9sWnJSX2hGbGY4VVJKclYzeGowWmt2ai12bWZVbC1EaXZJZw?oc=5","date":"2023-03-24","type":"pipeline","source":"Pharmaceutical Technology","summary":"Pharma Fix: The quest for the next tuberculosis vaccine - - Pharmaceutical Technology","headline":"Pharma Fix: The quest for the next tuberculosis vaccine -","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxNbHI2U290RmE1OW84QXg5TERBdmIwN3VYeUF1UU9lRjZXT0JpVHdMeVdaOTdubXRlUk54YXRzS3FCblB1TW1VTllwQnB2NUc2UjAwVUZBU0tUbzJXbUxvdUQxSmtEVnoyNk5vTDFXY19PMzRVM3F4N1VNNHdIeGFWempLdE9CblFlVlluOEJTM0NNY0pHZHYtb2FLTzRDMGFpSURjeEJ4NDdCS3I5ZVNsU2tTSHRBSktiNWRhcDhBOUhMOXJaSFlOQi0xUnlMUVZ3elY5dVVqWHNhT1VKVGVuMFN1czFfWEtxNERCUTdRdHl3eklqU1Rj?oc=5","date":"2021-07-14","type":"trial","source":"IAVI","summary":"Spanish pharmaceutical company Zendal and IAVI partner to advance the tuberculosis vaccine candidate MTBVAC into efficacy trials - IAVI","headline":"Spanish pharmaceutical company Zendal and IAVI partner to advance the tuberculosis vaccine candidate MTBVAC into efficac","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiW0FVX3lxTE5NOXRxVWNVOXpsMHcyb01meXdpREhmRWRZcnloOV9IWnQ3akxvWXhDZXQ2Uko5Z1h2ZWZEbE1KMEswVXNkaG5hVWM4U2ZMTHBaUllvdU5JdWFBVnc?oc=5","date":"2019-11-14","type":"pipeline","source":"Nature","summary":"Ending TB in India key to global elimination goals - Nature","headline":"Ending TB in India key to global elimination goals","sentiment":"neutral"}],"patents":[],"drugCount":4,"phaseCounts":{"phase_3":4},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}